Green synthesis, characterization, in silico molecular docking and biological evaluation of imidazolylchalcones as promising fungicide/s and nematicide/s
{"title":"Green synthesis, characterization, in silico molecular docking and biological evaluation of imidazolylchalcones as promising fungicide/s and nematicide/s","authors":"Rakesh Kumar, Parshant Kaushik, Kailashpati Tripathi, Rajni Godara, Sameer Ranjan Misra, Vijay Kumar, Partha Chandra Mondal, Jeetram, Pankaj, Virendra Singh Rana, V. Shanmugam, Dilip Khatri, Najam Akhtar Shakil","doi":"10.1186/s13065-025-01451-z","DOIUrl":null,"url":null,"abstract":"<div><p>Chalcones are known for their broad biological activities, which can be enhanced by incorporating heterocyclic moieties. Imidazole, recognized for its diverse properties, was introduced into a series of imidazolylchalcone derivatives (3a–3o) synthesized via Claisen-Schmidt condensation of benzaldehydes (2a–2o) and 4-(Imidazol-1-yl) acetophenone (1a) using ultrasonication as a green method. These compounds were characterized by spectroscopic techniques such as 1H-NMR, 13C-NMR, LC-HRMS and evaluated for fungicidal and nematicidal activity. Compound 3 h showed highest fungicidal activity against <i>Rhizoctonia solani</i> (ED₅₀ = 0.69 μg/mL), outperforming commercial hexaconazole (ED₅₀ = 3.57 μg/mL). Compound 3d exhibited the highest activity against <i>Fusarium oxysporum</i> (ED₅₀ = 119.22 μg/mL), while 3f was most effective against <i>Meloidogyne incognita</i> (LC₅₀ = 33.62 μg/mL), though less active than commercial Velum Prime (LC₅₀ = 3.46 μg/mL). The compounds potential activity may results from interactions of electronegative atom with enzyme active sites via hydrogen bonding. Docking studies against fungal cutinase and nematode acetylcholinesterase supported the in-vitro findings. Promising compounds will undergo further in-vivo and field trials for antifungal and antinemic applications and developed a potent molecule.</p><h3>Graphical Abstract</h3>\n<div><figure><div><div><picture><source><img></source></picture></div></div></figure></div></div>","PeriodicalId":496,"journal":{"name":"BMC Chemistry","volume":"19 1","pages":""},"PeriodicalIF":4.3000,"publicationDate":"2025-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://bmcchem.biomedcentral.com/counter/pdf/10.1186/s13065-025-01451-z","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMC Chemistry","FirstCategoryId":"92","ListUrlMain":"https://link.springer.com/article/10.1186/s13065-025-01451-z","RegionNum":2,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CHEMISTRY, MULTIDISCIPLINARY","Score":null,"Total":0}
引用次数: 0
Abstract
Chalcones are known for their broad biological activities, which can be enhanced by incorporating heterocyclic moieties. Imidazole, recognized for its diverse properties, was introduced into a series of imidazolylchalcone derivatives (3a–3o) synthesized via Claisen-Schmidt condensation of benzaldehydes (2a–2o) and 4-(Imidazol-1-yl) acetophenone (1a) using ultrasonication as a green method. These compounds were characterized by spectroscopic techniques such as 1H-NMR, 13C-NMR, LC-HRMS and evaluated for fungicidal and nematicidal activity. Compound 3 h showed highest fungicidal activity against Rhizoctonia solani (ED₅₀ = 0.69 μg/mL), outperforming commercial hexaconazole (ED₅₀ = 3.57 μg/mL). Compound 3d exhibited the highest activity against Fusarium oxysporum (ED₅₀ = 119.22 μg/mL), while 3f was most effective against Meloidogyne incognita (LC₅₀ = 33.62 μg/mL), though less active than commercial Velum Prime (LC₅₀ = 3.46 μg/mL). The compounds potential activity may results from interactions of electronegative atom with enzyme active sites via hydrogen bonding. Docking studies against fungal cutinase and nematode acetylcholinesterase supported the in-vitro findings. Promising compounds will undergo further in-vivo and field trials for antifungal and antinemic applications and developed a potent molecule.
期刊介绍:
BMC Chemistry, formerly known as Chemistry Central Journal, is now part of the BMC series journals family.
Chemistry Central Journal has served the chemistry community as a trusted open access resource for more than 10 years – and we are delighted to announce the next step on its journey. In January 2019 the journal has been renamed BMC Chemistry and now strengthens the BMC series footprint in the physical sciences by publishing quality articles and by pushing the boundaries of open chemistry.